Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan Biomaterial Revenue

Taiwan Biomaterial had revenue of 72.78M TWD in the quarter ending September 30, 2025, with 164.73% growth. This brings the company's revenue in the last twelve months to 203.27M, up 142.73% year-over-year. In the year 2024, Taiwan Biomaterial had annual revenue of 96.57M with 32.59% growth.

• Revenue (ttm): 203.27M
• Revenue Growth: +142.73%
• P/S Ratio: 8.38
• Revenue / Employee: 5.81M
• Employees: 35
• Market Cap: 1.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	96.57M	23.74M	32.59%
Dec 31, 2023	72.84M	-54.47M	-42.79%
Dec 31, 2022	127.31M	85.63M	205.48%
Dec 31, 2021	41.67M	23.60M	130.56%
Dec 31, 2020	18.08M	1.53M	9.26%